Literature DB >> 7700019

Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers.

P Giovenali1, D Fenocchio, G Montanari, C Cancellotti, S D'Iddio, U Buoncristiani, M Pelagaggia, R Ribacchi.   

Abstract

Biopsies were taken from the vastus lateralis muscle of 26 chronic uremic patients before and after a 24-week treatment with L-carnitine given at the dose of 2 g i.v. at the end of hemodialysis, or in dialysis solution, or per os twice daily. The aim of the study was to evaluate both the muscle morphology in dialyzed subjects and the modification provoked by the therapy. All patients manifested a significant, even if variable, degree of muscular atrophy which involved all types of muscle fibers. After the treatment there was an increase of about 7% in the diameter of type I and type IIa fibers, which can utilize carnitine for fatty acid oxidation to produce energy, and a reduction in the atrophic fibers. No noteworthy changes were documented in type IIb fibers, which depend on glycolysis for energy production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7700019     DOI: 10.1038/ki.1994.460

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

Review 1.  Morphological, electrophysiological, and metabolic characteristics of skeletal muscle in people with end-stage renal disease: a critical review.

Authors:  Anuradha Sawant; S Jayne Garland; Andrew A House; Tom J Overend
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

2.  Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation.

Authors:  Liza Makowski; Robert C Noland; Timothy R Koves; Weibing Xing; Olga R Ilkayeva; Michael J Muehlbauer; Robert D Stevens; Deborah M Muoio
Journal:  FASEB J       Date:  2008-10-22       Impact factor: 5.191

Review 3.  Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2013-03-19       Impact factor: 5.614

4.  l-carnitine and cancer cachexia: Clinical and experimental aspects.

Authors:  Renata Silvério; Alessandro Laviano; Filippo Rossi Fanelli; Marília Seelaender
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-01-26       Impact factor: 12.910

5.  Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy.

Authors:  A C Gimenes; D M Bravo; L M Nápolis; M T Mello; A S B Oliveira; J A Neder; L E Nery
Journal:  Braz J Med Biol Res       Date:  2015-02-24       Impact factor: 2.590

6.  An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure.

Authors:  Zhi-Hao Zhang; Nosratola D Vaziri; Feng Wei; Xian-Long Cheng; Xu Bai; Ying-Yong Zhao
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

7.  L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis.

Authors:  Masatsugu Ohara; Koji Ogawa; Goki Suda; Megumi Kimura; Osamu Maehara; Tomoe Shimazaki; Kazuharu Suzuki; Akihisa Nakamura; Machiko Umemura; Takaaki Izumi; Naoki Kawagishi; Masato Nakai; Takuya Sho; Mitsuteru Natsuizaka; Kenichi Morikawa; Shunsuke Ohnishi; Naoya Sakamoto
Journal:  Hepatol Commun       Date:  2018-08-06

8.  Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis.

Authors:  Tatsunori Hanai; Makoto Shiraki; Kenji Imai; Atsushi Suetugu; Koji Takai; Masahito Shimizu
Journal:  Nutrients       Date:  2020-06-29       Impact factor: 5.717

9.  The effects of oral L-carnitine supplementation on physical capacity and lipid metabolism in chronic hemodialysis patients.

Authors:  Yasuo Kudoh; Shinya Aoyama; Takaaki Torii; Qijie Chen; Daigo Nagahara; Hiromi Sakata; Akihiko Nozawa
Journal:  Nephron Extra       Date:  2014-03-25

10.  Creatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle.

Authors:  Giuseppe D'Antona; Seyed Mohammad Nabavi; Piero Micheletti; Arianna Di Lorenzo; Roberto Aquilani; Enzo Nisoli; Mariangela Rondanelli; Maria Daglia
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.